Changeflow GovPing Healthcare Appco Pharma LLC Suitability Petition
Routine Guidance Added Final

Appco Pharma LLC Suitability Petition

Favicon for www.regulations.gov Regs.gov: Food and Drug Administration
Detected March 28th, 2026
Email

Summary

The Food and Drug Administration (FDA) has received a suitability petition from Appco Pharma LLC. The petition is related to drug manufacturing and regulatory filings.

View original document View source feed page

What changed

The Food and Drug Administration (FDA) has received a suitability petition filed by Appco Pharma LLC. This filing indicates a specific request or submission made by the pharmaceutical company to the agency, likely concerning aspects of drug development, manufacturing, or marketing.

While the document itself is not available for download, its existence as a filed petition suggests that Appco Pharma LLC is seeking agency review or approval on a particular matter. Compliance officers should note that this is a filing event, and further details regarding the petition's content or any subsequent FDA actions would require access to the actual document or further announcements.

Source document (simplified)

Content

There are no documents available to view or download

Attachments 1

Suitability Petition from Appco Pharma LLC

More Information
- Author(s) CDER
Download

Related changes

Favicon for www.regulations.gov FDA Complaint Document Details
Routine Mar 28, 2026 • Regs.gov: Food and Drug Administration • Healthcare
Favicon for www.regulations.gov FDA Complaint Filed and Closed for Comments
Priority review Mar 28, 2026 • Regs.gov: Food and Drug Administration • Healthcare
Favicon for www.regulations.gov FDA Complaint Document Posted
Routine Mar 28, 2026 • Regs.gov: Food and Drug Administration • Healthcare
Favicon for www.jdsupra.com EU Privacy Regulators Issue Opinion on Proposed Biotech Act
Priority review Mar 28, 2026 • JD Supra Healthcare • Healthcare
Favicon for changeflow.com ACME UNITED CORPORATION Class II Recall: BZK Antiseptic Towelettes
Urgent Mar 28, 2026 • FDA: Drug Recalls Class II • Pharma & Drug Safety
Favicon for changeflow.com HTO Nevada Inc. Recalls Lidocaine Cream Due to Stability Data
Urgent Mar 28, 2026 • FDA: Drug Recalls Class II • Pharma & Drug Safety

Source

Favicon for www.regulations.gov
Regs.gov: Food and Drug Administration regulations.gov/search?agencyIds=FDA&sortBy=postedDate&sortDirection=desc
Healthcare
Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
FDA
Instrument
Guidance
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
FDA-2026-P-3242-0001
Docket
FDA-2026-P-3242-0001

Who this affects

Applies to
Drug manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Drug Manufacturing Regulatory Filings
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Compliance
Compliance frameworks
FDA 21 CFR Part 11 GxP
Topics
Drug Approval Regulatory Filings

Browse Categories

Agriculture & Food Safety 62 AI Regulation 3 Banking & Finance 246 Consumer Protection 41 Courts & Legal 355 Data Privacy & Cybersecurity 67 Defense & National Security 49 Education 20 Energy 105 Environment 84 Government & Legislation 270 Healthcare 135 Housing 16 Immigration 9 Insurance 56 Labor & Employment 114 Legal & Courts 1 Pharma & Drug Safety 101 Securities & Markets 84 Tax 65 Tax & Revenue 1 Telecom & Technology 47 Trade & Sanctions 124 Transportation 56

Get Healthcare alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when Regs.gov: Food and Drug Administration publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.